FOXC2 and neoplasm: By immunohistochemistical analysis, Prox1 was shown to be closely associated with tumor progression (T factor and clinical stage), nodal metastasis, and LVD, and FOXC2 expression was shown to be significantly correlated with MVD in OSCCs.